The company earns the No. 242 rank among its peers in the Medical-Biomed/Biotech industry group. Genmab ( GMAB ), Horizon Pharma ( HZNP ) and Alexion Pharmaceuticals ( ALXN ) are among the top 5 highly rated stocks within the group.